- Advertisement -
A biotech stock focused on herbal medicine has surged by more than 64,000 per cent so far this year, although the company has made zero revenue, much less turned a profit.The unbelievable rally has transformed Regencell Bioscience Holdings, a penny stock as recently as April, to one worth more…
Click here to view the original article.
